Combined treatment with artesunate and bromocriptine has synergistic anticancer effects in pituitary adenoma cell lines

Prolactinomas are the most prevalent functional pituitary adenomas. The preferred treatments for prolactinomas are dopamine agonists (DAs) such as bromocriptine (BRC), but DAs still have the challenges of tumor recurrence and drug resistance. This study demonstrates that the synergy of function and...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Xin, Du, Qiu, Mao, Zhigang, Fan, Xiang, Hu, Bin, Wang, Zhen, Chen, Zhiyong, Jiang, Xiaobing, Wang, Zongming, Lei, Ni, Wang, Haijun, Zhu, Yonghong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5542234/
https://www.ncbi.nlm.nih.gov/pubmed/28501857
http://dx.doi.org/10.18632/oncotarget.17437

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5542234/
https://www.ncbi.nlm.nih.gov/pubmed/28501857
http://dx.doi.org/10.18632/oncotarget.17437

Ejemplares similares